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Brief Conclusive Report

The microenvironment of visceral adipose
tissue and liver alter natural killer cell viability
and function
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ABSTRACT
The role of NK cells in visceral adipose tissue (VAT) and
liver inflammation in obesity is not fully understood. This
study investigated the frequency, cytokine expression,
chemokine receptor, and cytotoxicity receptor profile of
NK cells in the blood, omentum, and liver of patients with
the obesity-associated cancer, oesophageal adenocarcinoma (OAC). The effect of chronically inflamed tissue
microenvironments on NK cell viability and function was
also examined. We identified significantly lower NK cell
frequencies in the liver of OAC patients compared with
healthy controls and within the omentum and liver of OAC
patients compared with blood, whereas IL-10-producing
populations were significantly higher. Interestingly, our
data suggest that reduced frequencies of NK cells in
omentum and liver of OAC patients are not a result of
impaired NK cell chemotaxis to these tissues. In fact, our
functional data revealed that secreted factors from
omentum and liver of OAC patients induce significant
levels of NK cell death and lead to reduced percentages
of TNF-a+ and NKP46+ NK cells and higher frequencies of
IL-10-producing NK cells. Together, these data suggest
that the omental and hepatic microenvironments of OAC
patients alter the NK cell phenotype to a more antiinflammatory homeostatic role. J. Leukoc. Biol.
100: 1435–1442; 2016.

[3] and others [4] have previously identiﬁed macrophages and
T cells as key players in adipose tissue inﬂammation, but the role
of NK cells has not been fully deﬁned in human obesity.
Furthermore, whereas previous studies have revealed intriguing
alterations in NK cell numbers and phenotypes within the VAT,
they have not uncovered why NK cell frequencies are altered in
obesity nor elucidated the reciprocal effects of the inﬂamed VAT
microenvironment on their function, particularly in obesityassociated cancer [5, 6]. Moreover, whereas NK cells have been
studied extensively in viral hepatitis and have already been shown
to be protective in liver ﬁbrosis, their role in the inﬂamed fatty
liver has not been identiﬁed [7, 8].
This study uniquely examined the frequencies, cytokine
expression, chemokine receptor expression, and NCR proﬁles of
NK cells in the omentum and liver of patients with the obesityassociated malignancy, OAC [1], and addressed the inﬂuence of
such tissue microenvironments on NK cell viability and function.
We report herein that NK cell frequencies are lower in the liver
of OAC patients compared with noncancer controls and within
the inﬂamed omentum and liver of OAC patients compared with
blood. In addition, we demonstrate that secreted factors from
these tissue microenvironments can induce signiﬁcant changes
in NK cell viability, cytokine expression, and NCR proﬁles.

MATERIALS AND METHODS
Introduction
The burgeoning obesity epidemic is associated with increased
prevalence of both cancer and nonalcoholic fatty liver disease
and is attributable for ;3.5 million deaths every year [1, 2]. We
Abbreviations: ACM = adipose conditioned media, APC = allophycocyanin,
BMI = body mass index, HCV = hepatitis C virus, LCM = liver conditioned
media, M199 = medium 199, NCR = natural cytotoxicity receptor, OAC =
oesophageal adenocarcinoma, PI = propidium iodide, VAT = visceral
adipose tissue, VFA = visceral fat area
The online version of this paper, found at www.jleukbio.org, includes
supplemental information.
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Subjects
Fifteen consecutive OAC patients, attending the National Oesophageal and
Gastric Centre at St. James’s Hospital (Dublin, Ireland) were enrolled in this
study. The group included 12 men and 3 women (with an average age of
63.9 yr), and 73.3% had received neo-adjuvant chemoradiotherapy, and
93.3% were overweight or obese with a mean BMI of 28.02 kg/m2 and mean
VFA of 169.5 cm2 [9]. There were no metastases in the omentum or liver of
this cohort.

1. Correspondence: Tumour Immunology Group, Dept. of Surgery, Trinity
Translational Medicine Institute, St. James’s Hospital, Dublin 8, Ireland.
E-mail: jlysaght@tcd.ie
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Blood and omentum were taken from noncancer control subjects
attending St. James’s Hospital. Noncancer control liver was taken from
donor livers at the Liver Transplant Unit, St. Vincent’s University Hospital
(Dublin, Ireland). Patients provided informed consent for sample acquisition, and the study received ethical approval from the St. James’s Hospital
Ethics Review Board and St. Vincent’s University Hospital Ethics Committee. BMI, VFA, and anthropometric variables were measured, as described
previously [3, 9].

Statistical analyses
Statistical analysis was carried out using Prism GraphPad Version 5.0
(GraphPad Software, La Jolla, CA, USA). Differences between groups were
assessed using the paired (Wilcoxon signed-rank) or unpaired (Mann-Whitney
U) t test where appropriate. P , 0.05 was considered signiﬁcant.

RESULTS AND DISCUSSION

Sample preparation
PBMCs were isolated by density centrifugation. Omental samples were
prepared as described previously but with a shorter collagenase treatment
time of 15 min to prevent loss of surface CD56 [3]. Liver samples were
processed, as described in Curry et al. [10], with modiﬁcations to replace the
density centrifugation step with the use of a red cell lysis step. Healthy donor
livers were perfused, and hepatic mononuclear cells were isolated, as
described previously [11]. ACM was prepared as described previously [3].
LCM was prepared by adding 350 ml serum-free M199 media/0.1 g minced
liver and incubating at 37°C, 5% CO2, for 72 h. The media was ﬁltered, tissue
discarded, and the remaining supernatant was used as LCM for subsequent
experiments.

Quantiﬁcation of pro- and anti-inﬂammatory NK cells
and phenotypical analysis of NCR and chemokine
receptor proﬁles
Single-cell suspensions from blood, omentum, and liver were stained with
CD3-APC-Cy7 (BioLegend, San Diego, CA, USA) and CD56-APC, CD56-FITC,
NKP46-PE, NKP30-APC, NKG2D-APC, CCR5-FITC, CXCR3-PE, CCR1-APC,
CCR2-APC, CXCR2-FITC, CCR3-PE, and CCR6-APC (Miltenyi Biotec,
Bergisch Gladbach, Germany). NK cells were quantiﬁed as CD56+CD32 cells
within the lymphocyte gate. For cytokine proﬁling and degranulation assay,
cells were stimulated with PMA (10 ng/ml) and ionomycin (1 mg/ml) for 1 h.
PE-conjugated anti-CD107a (BD Biosciences UK, Oxford, United Kingdom)
was added at this time to detect degranulation, followed by the addition of
brefeldin A (10 mg/ml) for a further 3 h. Subsequent staining with IFNg-V500, TNF-a-APC, and IL-10-PE (BD Biosciences UK) was performed. Cells
were acquired using a CyAn ADP ﬂow cytometer (Beckman Coulter, Brea, CA,
USA) and analyzed with FlowJo software (Tree Star, Ashland, OR, USA).

NK cell chemotaxis assays
Chemotaxis was assessed using a 5 mm pore Transwell ﬁlter system. NK cells
from the blood of 6 OAC patients and 3 noncancer controls were added to the
top chamber at a density of 0.2 3 106 cells/100 ml RPMI and incubated for 2 h
at 37°C. CountBright Beads were used to enumerate the number of migrated
NK cells.

Culture of NK cells in ACM and LCM
PBMCs from 8 healthy donors were cultured in 500 ml RPMI and
supplemented with 500 ml serum-free M199 or ACM or LCM for 48 h at 37°C.
Following incubation, ﬂow cytometric analysis of CD56, CD3, NKP46, NKP30,
NKG2D, IFN-g, TNF-a, and IL-10 expression was performed. Staining with
Annexin V-FITC (IQ Products, Groningen, Netherlands) and PI (Thermo
Fisher Scientiﬁc, Waltham, MA, USA) was carried out to detect apoptotic and
necrotic cells.

NK cell-mediated cytotoxicity assay
Natural and IL-2-induced cytotoxicity by PBMCs from 3 healthy donors against
the myeloid erythroleukemia-derived cell line K562 cells was measured using
the Cell-Mediated Cytotoxicity Assay (ImmunoChemistry Technologies,
Bloomington, MN, USA) following culture in 500 ml complete RPMI,
supplemented with 500 ml serum-free M199 or ACM or LCM, in the presence
or absence of 100 U/ml IL-2 at 37°C for 24 h. The cytotoxic capabilities were
evaluated at E:T ratios of 50:1.
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It is well-established that the omentum and liver of obese
individuals are sites of excessive inﬂammation, fueled in part by
an abundance of proinﬂammatory Th1 cells and M1 macrophages [12, 13]. More recently, NK cells have also been
identiﬁed as mediators of adipose tissue inﬂammation and
insulin resistance [6, 14]. However, to date, no studies have
examined the effects of these inﬂamed tissue microenvironments
on NK cells. Herein, we have addressed the prevalence and
inﬂammatory proﬁles of NK cells in the omentum and liver of
patients with OAC, an exemplar model of an obesity-associated
cancer, together with the effects of these microenvironments on
NK cell viability and function.

Signiﬁcantly lower frequencies of NK cells in the
omentum and liver of OAC patients compared with
patient-matched blood
To ascertain whether NK cell numbers differed between the
circulation, the omentum, and liver of OAC patients and
noncancer control subjects, the frequencies of CD56+CD32 (NK)
cells were quantiﬁed as a percentage of lymphocytes in the blood,
omentum, and liver of 14 OAC patients, in the blood of 7, and in
the omentum and liver of 3 noncancer control patients (Fig. 1A).
This analysis identiﬁed signiﬁcantly fewer NK cells in OAC
omentum and liver, relative to matched blood: Blood vs.
Omentum (12.42% vs. 2.24%; P , 0.0001) and Blood vs. Liver
(12.42% vs. 3.73%; P = 0.009; Fig. 1B). Comparisons between
noncancer controls and OAC patients revealed that the NK cell
frequencies in OAC liver are signiﬁcantly lower than those of
noncancer controls; however, the peripheral blood and omental
proportions were similar between patient cohorts, which may be
more reﬂective of the physiological state at these sites: Noncancer Liver vs. OAC Liver (29.18% vs. 3.73%; P = 0.009; Fig. 1C).
Interestingly, the proportions of CD56BRIGHT NK cells were
signiﬁcantly higher in OAC blood compared with noncancer
controls, whereas the proportions of CD56DIM NK cells were
signiﬁcantly lower, suggesting that the frequencies of circulating
cytokine-producing NK cells are expanded in the cancer cohort:
Noncancer Blood vs. OAC Blood (CD56BRIGHT: 3.15% vs. 6.7%,
P = 0.008; CD56DIM: 96.85% vs. 93.3%, P = 0.009; Fig. 1D).
However, no signiﬁcant differences were observed in the
proportions of CD56BRIGHT and CD56DIM NK cells in the
omental or liver tissues (Fig. 1D).
These data suggest that the underlying malignancy somehow
perpetuates the loss of NK cells from the liver. Reductions in NK
cell frequencies have previously been reported in the tumor
regions of liver in patients with hepatocellular carcinoma [15].
However, the livers used in our study were tumor free. Previous
studies in viral hepatitis report observations that NK cell
frequencies are altered in patients with liver inﬂammation, and
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Figure 1. Signiﬁcantly lower frequencies of NK cells in the omentum and liver of OAC patients compared with matched blood. (A) Representative
dot plots of NK cell gating as CD56+CD32 lymphocytes in blood, omentum, and liver. (B) The frequencies of CD56+CD32 (NK) cells as a
percentage of total lymphocytes in the blood, omentum, and liver of 14 OAC patients (**P , 0.005, ***P , 0.0005 by paired t test). (C) The
frequencies of CD56+CD32 (NK) cells as a percentage of total lymphocytes in the blood of 7 noncancer controls and omentum and liver of 3
noncancer controls (patterned bars) and 14 OAC patients (black bars; **P , 0.005 by unpaired t test). (D) The frequencies of CD56DIM and
CD56BRIGHT NK cells as a percentage of total NK cells in the blood of 7 noncancer controls and omentum and liver of 3 noncancer controls
(patterned bars) and 14 OAC patients (black bars; **P , 0.005 by unpaired t test).

we propose that depletions of NK cells in OAC liver compared
with both matched blood and noncancer control liver might
represent a consequence of hepatic inﬂammation in obesityassociated cancer [16, 17].

Signiﬁcantly higher proportions of IL-10-producing NK
cells are found in OAC omentum and liver relative to
matched blood
To examine whether the observed differences in NK cell
frequencies among blood, omentum, and liver were accompanied by differences in NK cell inﬂammatory proﬁle, the
frequencies of IFN-g-, TNF-a-, and IL-10-producing NK cells were
assessed in the blood, omentum, and liver of 7 OAC patients.
Signiﬁcantly greater frequencies of IL-10-producing NK cells
were observed in the omentum and liver compared with matched
blood in the cancer cohort: Blood vs. Omentum (2.1% vs. 12.4%;
P = 0.02) and Blood vs. Liver (2.1% vs. 19.8%; P = 0.04; Fig. 2A).
However, whereas there was an abundance of IFN-g- and TNFa-producing NK cells in OAC omentum and liver, their
frequencies were not signiﬁcantly different than that in the
matched blood: IFN-g, Blood versus Omentum (21.7% vs. 39.3%;
P = 0.1) and Blood vs. Liver (21.7% vs. 43.9%; P = 0.2); and TNFa, Blood vs. Omentum (8.3% vs. 18.8%; P = 0.2) and Blood vs.
Liver (8.3% vs. 13.8%; P = 0.2; Fig. 2A). The IL-10-producing
capabilities of NK cells have been previously implicated in
limiting immune-mediated damage in viral hepatitis and within
the uterine microenvironment, and in our cohort, they may
serve to limit pathological obesity-associated inﬂammation
[17, 18].

www.jleukbio.org

Signiﬁcantly lower NKP46+ compartments in the NK
cell population within OAC omentum and liver relative
to matched blood
As there appeared to be an enrichment of anti-inﬂammatory NK
cells in the omentum and liver of OAC patients, their NCR
expression was also examined in ex vivo tissues to identify any
alterations in NK cell activation. This study revealed signiﬁcantly
lower frequencies of NKP46+ NK cells in the omentum and liver
of OAC patients compared with blood: Blood vs. Omentum
(71.7% vs. 19.7%; P = 0.03) and Blood vs. Liver (71.7% vs. 35.3%;
P = 0.04; Fig. 2B and C). However, frequencies of NKP30+ and
NKG2D+ NK cells were not signiﬁcantly different: NKP30, Blood
vs. Omentum (16.7% vs. 16.7%; P = 0.6) and Blood vs. Liver
(16.7% vs. 9.4%; P = 0.4); NKG2D, Blood vs. Omentum (15.2%
vs. 13.1%; P = 0.9) and Blood vs. Liver (15.2% vs. 19.4%; P = 0.6;
Fig. 2B). These data suggest that the prevalence of NK cells,
particularly the NKP46+ compartment, is low in OAC omentum
and liver but provide no indication of whether they are depleted
in these tissues or whether their trafﬁcking toward these sites is
impaired.

Migration of OAC-derived NK cells to the adipose
tissue and liver-conditioned media of OAC patients is
not signiﬁcantly different to that of noncancer, controlderived NK cells, whereas CCR5+ NK cells are
signiﬁcantly enriched in OAC omentum
Ex vivo chemotaxis assays were performed to address whether
the lower NK cell numbers in OAC omentum and liver were a
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Figure 2. Signiﬁcantly higher percentages of anti-inﬂammatory NK cells in OAC omentum and liver relative to matched blood, whereas NKP46+ NK cell
frequencies are signiﬁcantly lower. (A) The frequencies of IFN-g-, TNF-a-, and IL-10-expressing NK cells as a percentage of total NK cells in
the blood, omentum, and liver of 7 OAC patients (*P , 0.05). (B) The frequencies of NKP46 + , NKP30 + , and NKG2D + NK cells as a
percentage of total NK cells in the blood, omentum, and liver of 5 OAC patients (*P , 0.05). (C) Representative dot plot showing gating
of IFN-g-, TNF-a-, IL-10-, NKP46-, NKP30-, and NKG2D-expressing CD56 + cells, previously gated on the total lymphocyte population.

result of reduced NK cell migration toward these tissues. Our data
revealed that NK cells isolated from the blood of OAC patients
preferentially migrate toward ACM and LCM generated from 6
OAC patients when compared with M199 media alone. This
suggests that NK cell chemotaxis to secreted factors from
omentum and liver is not impaired in OAC; fold-change migration
to M199 vs. ACM (1 vs. 8.2; P = 0.1) and M199 vs. LCM (1 vs. 4.4;
P = 0.04; Fig. 3A). Moreover, noncancer control blood-derived NK
cells migrated to ACM and LCM at lower numbers than OACderived NK cells, further indicating that NK cell migratory
capacity is not impaired in OAC: Noncancer vs. OAC
migration to ACM (4.3 vs. 8.2; P = 0.2) and Noncancer vs.
OAC migration to LCM (2.6 vs. 4.4; P = 0.1; Fig. 3A).
Phenotypic analysis of chemokine receptor expression by NK
cells in the blood, omentum, and liver revealed that CCR5+
NK cell frequencies were signiﬁcantly higher in OAC
omentum and substantially higher in OAC liver compared
with blood: Blood vs. Omentum (32.8 vs. 58.7; P = 0.03) and
Blood vs. Liver (32.8% vs. 51.2%; P = 0.4; Fig. 3B). These data
suggest that NK cells can effectively migrate to omentum and
1438
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liver in OAC, and it is likely that CCR5 ligands are among the
chemokines that play a key role in such chemotaxis. However,
further work is needed to conﬁrm the speciﬁc chemokine
pathways guiding NK cells to these tissues.

Signiﬁcantly higher levels of NK cell death were
observed following culture in adipose tissue and liver
conditioned media
As it appeared that NK cell migration to omentum and liver is not
impaired in OAC, it was proposed that reduced NK cell
frequencies in these tissues may be, at least in part, a result of
enhanced cell death. To assess the effects of the omental and
hepatic microenvironment on NK cell viability, PBMCs from 4
healthy donors were cultured in ACM or LCM from OAC
patients for 48 h and subsequently stained with Annexin V and
PI. These studies revealed that soluble factors in OAC omentum
and liver resulted in signiﬁcantly increased NK cell but not T cell
death (Annexin V+ PI+ cells). Therefore, the depletion of NK
cells observed in the omentum and liver of OAC patients is, in
part, a result of secreted factors from these tissues. T cells
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Figure 3. NK cell chemotaxis to secreted factors
from omentum and liver is not impaired in OAC.
(A) Bar chart showing the fold-change migration
of noncancer control blood-derived (patterned
bars) and OAC patient blood-derived (black
bars) NK cells to M199 media alone (M199),
ACM, and LCM generated from 6 obese OAC
patients (*P , 0.05 by paired t test). (B) Bar
charts showing the frequencies of CCR5, CXCR3,
CCR6, CXCR2, CCR3, CCR1, and CCR2 expressing NK cells in the blood, omentum, and liver of
10 OAC patients. Frequencies are shown as a
percentage of the total CD56+CD32 (NK) cell
population (*P , 0.05 by paired t test).

cultured with OAC-derived ACM and LCM were not, however,
susceptible to such cell death, which is in line with their
prevalence in these tissues [3, 4]: NK cells, M199 vs. ACM (2.49%
vs. 15.27%; P = 0.05) and M199 vs. LCM (2.49% vs. 25.15%; P =
0.02); T cells, M199 vs. ACM (3.5% vs. 3.6%; P = 0.7) and M199
vs. LCM (3.5% vs. 4.4%; P = 0.6; Fig. 4A and B). Further
investigations revealed that noncancer control-derived ACM

www.jleukbio.org

induced substantial but nonsigniﬁcant levels of NK cell death,
whereas noncancer, control-derived LCM induced signiﬁcant
levels of NK cell death, suggesting that these changes in NK cell
viability are not limited to the omental and hepatic microenvironments of OAC patients and perhaps represent a normal
physiological function of these tissues: % Late apoptotic NK cells,
M199 vs. control ACM (4.6% vs. 22.6%; P = 0.06) and M199 vs.
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control LCM (4.6% vs. 15.9%; P = 0.02); T cells, M199 vs. control
ACM (1.6% vs. 8.9%; P = 0.2) and M199 vs. control LCM (1.6%
vs. 21.6%; P = 0.3; Fig. 4A). However, it must be noted that the
apoptosis-inducing capabilities of OAC-derived LCM are higher,
albeit nonsigniﬁcant, than that of the noncancer-derived LCM,
suggesting that NK cells from OAC patients may be more
susceptible to apoptotic signals from the liver (Control LCM vs.
OAC LCM: 15.9% vs. 25.15%; P = 0.4). It is also interesting to
note that T cell apoptosis is lower following culture with
conditioned media from the liver and omentum of OAC patients
compared with noncancer controls. This may lead to an
accumulation of inﬂammatory T cells at these sites in OAC, but
this requires further investigation.

Signiﬁcantly lower frequencies of TNF-a-producing and
NCR+ NK cells following culture in OAC-derived LCM
compared with media alone, whereas IL-10-producing
NK cells are signiﬁcantly higher
As soluble factors in the omental and hepatic microenvironment
appeared to induce NK cell death, their effects on the pro- and

anti-inﬂammatory compartments of NK cells were also examined.
The cytokine proﬁles of the remaining viable NK cells were
analyzed using ﬂow cytometry following 48 h culture in ACM and
LCM. Interestingly, signiﬁcant increases in IL-10-producing NK
cells were observed: M199 vs. ACM (1.1% vs. 6.3%; P = 0.02) and
M199 vs. LCM (1.1% vs. 5.6%; P = 0.008; Fig. 4C). However, of
most signiﬁcance was the reduction in TNF-a-expressing NK cells
following culture in LCM: M199 vs. ACM (31.4% vs. 25.1%;
P = 0.2), M199 vs. LCM (31.4% vs. 9.4%; P = 0.0004), and ACM vs.
LCM (25.1% vs. 9.4%; P = 0.02; Fig. 4C). In contrast to this, the
frequencies of IFN-g-expressing NK cells were not altered
signiﬁcantly: M199 vs. ACM (53.9% vs. 45.3%; P = 0.2) and M199
vs. LCM (53.9% vs. 44.1%; P = 0.2; Fig. 4C). Interestingly, further
investigations revealed substantial increases in IL-10-producing
NK cell frequencies when cultured in the presence of ACM or
LCM from noncancer control subjects (Fig. 4C). Furthermore,
TNF-a- and IFN-g-producing NK cells were signiﬁcantly less
abundant following culture in noncancer control-derived ACM
(P = 0.01), whereas these trends toward lower frequencies of
TNF-a and IFN-g producers were also observed following culture

Figure 4. Signiﬁcantly higher levels of NK cell death and signiﬁcant reductions in NCR+ and TNF-a+ proportions following culture in LCM. (A,
upper) The frequencies of Annexin V+ PI+ NK cells as a percentage of total NK cells (left) and Annexin V+ PI+ T cells as a percentage of total
T cells (right) from the blood of 4 healthy donors following 48 h of culture in M199 media, OAC-derived ACM, and OAC-derived LCM (*P , 0.05
by paired t test). (Lower) The frequencies of Annexin V+ PI+ NK cells as a percentage of total NK cells (left) and Annexin V+ PI+ T cells as a
percentage of total T cells (right) from the blood of 4 healthy donors following 48 h of culture in M199 media, noncancer control-derived ACM,
and noncancer control-derived LCM (*P , 0.05 by paired t test). (B) Representative dot plots of Annexin V+ PI+ NK cells, previously gated on
CD56+CD32 lymphocytes following 48 h of culture in M199 media, ACM, and LCM. (C, upper) The frequencies of IFN-g-, TNF-a-, and IL-10expressing NK cells as a percentage of total NK cells from the blood of 8 healthy donors following 48 h of culture in M199 media, OAC-derived
ACM, and OAC-derived LCM (*P , 0.05, **P , 0.005, by paired t test). (C, lower) The frequencies of IFN-g-, TNF-a-, and IL-10-expressing NK cells
as a percentage of total NK cells from the blood of 8 healthy donors following 48 h of culture in M199 media, noncancer control-derived ACM, and
noncancer control-derived LCM (*P , 0.05, by paired t test). (D) The frequencies of NKP46+, NKP30+, and NKG2D+ NK cells as a percentage of
total NK cells from the blood of 5 healthy donors following 48 h of culture in M199 media, OAC-derived ACM, and OAC-derived LCM (*P , 0.05,
**P , 0.005, by paired t test).
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in LCM, but this was not statistically signiﬁcant (TNF-a, P = 0.1;
IFN-g, P = 0.06; Fig. 4C). Together with our observations in the
cancer patient cohort, these data suggest that proinﬂammatory
NK cell frequencies are naturally controlled in liver and
omentum, perhaps to maintain a more homeostatic state,
reﬂective of the tolerogenic microenvironment of the liver. Our
data support a previous study that demonstrated a phenotypic
switch in NK cells from a proinﬂammatory to an antiinﬂammatory phenotype in response to systemic inﬂammation in
toxoplasmosis [19]. In the context of obesity, proinﬂammatory
cytokine-producing NK cells have recently been implicated in
adipose tissue stress and insulin resistance [6]. Therefore, it is
possible that the depletions in TNF-a-producing NK cells and
increases in IL-10-producing NK cells reported here are a means
of limiting inﬂammation and maintaining immune homeostasis
in the tissue microenvironments of omentum and liver. However,
further studies are needed to elucidate fully the mechanisms
through which this might occur.
Frequencies of NCR+ NK cells of 5 healthy subjects were also
quantiﬁed following 48 h culture in ACM and LCM. NKP46+ NK
cell frequencies were reduced signiﬁcantly following 48 h of
culture in ACM and LCM: M199 vs. ACM (89.3% vs. 42.4%;
P = 0.007) and M199 vs. LCM (89.3% vs. 52.9%; P = 0.02; Fig. 4D).
NKG2D+ NK cell frequencies were signiﬁcantly reduced following 48 h of culture in LCM: M199 vs. ACM (39.7% vs. 35.2%;
P = 0.6) and M199 vs. LCM (39.7% vs. 15.4%; P = 0.02), whereas
NKP30+ NK cell frequencies were signiﬁcantly reduced following
48 h of culture in ACM: M199 vs. ACM (10.6% vs. 7.2%;
P = 0.005) and M199 vs. LCM (10.6% vs. 9.1%; P = 0.4; Fig. 4D).
Similar trends were observed with mean ﬂuorescence intensity
values for these markers (data not shown). These data indicate
that NCR surface expression is reduced by soluble factors in ACM
and LCM, suggesting that the omental and hepatic tissue
microenvironments can inﬂuence NK cell activation. Whereas
others have reported that cytotoxicity of intrahepatic NK cells is
impaired in the inﬂamed liver of patients with chronic HCV, and
our data indicate signiﬁcant alterations in NCR expression in
OAC omentum and liver, our supplemental data suggest that NK
cell cytotoxicity against K562 cells is unaffected by secreted
factors in ACM and LCM (Supplemental Fig. 1) [20]. As NKP46+
NK cells previously have been shown to mediate M1 polarization
and adipose tissue inﬂammation and contribute to insulin
resistance, it is possible that their depletion in our cohort is
another means of controlling not just inﬂammation but also
metabolic dysfunction [6]. Furthermore, NKP46 expression by
NK cells has been associated with liver inﬂammation and
immune-mediated liver damage in HCV, and therefore, its
modulation in OAC patient liver might also be a means of
limiting pathology in the inﬂamed hepatic microenvironment [21].

Concluding remarks
For the ﬁrst time, we have shown depletions in inﬂammatory NK
cell frequencies in the omentum and liver of patients with the
obesity-associated malignancy, OAC. Our mechanistic studies
indicate that this may be, at least in part, a result of increased NK
cell death. These data suggest that the microenvironments of
omentum and liver promote an anti-inﬂammatory NK cell
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cytokine proﬁle with a reduction in proinﬂammatory NKP46+ NK
cell populations. In light of these data and previous studies that
identiﬁed proinﬂammatory NK cells as mediators of insulin
resistance, we propose that an enhancement of NK cell bias
toward an anti-inﬂammatory phenotype may have potential as an
immunotherapy to alleviate pathologic inﬂammation in obesity
and liver disease.
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